Cargando…
Sustained peripheral depletion of amyloid-β with a novel form of neprilysin does not affect central levels of amyloid-β
Alzheimer’s disease is characterized by the accumulation of amyloid deposits in the brain and the progressive loss of cognitive functions. Although the precise role of amyloid-β in disease progression remains somewhat controversial, many efforts to halt or reverse disease progression have focussed o...
Autores principales: | Henderson, Simon J., Andersson, Christin, Narwal, Rajesh, Janson, Juliette, Goldschmidt, Tom J., Appelkvist, Paulina, Bogstedt, Anna, Steffen, Ann-Charlott, Haupts, Ulrich, Tebbe, Jan, Freskgård, Per Ola, Jermutus, Lutz, Burrell, Matthew, Fowler, Susan B., Webster, Carl I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914468/ https://www.ncbi.nlm.nih.gov/pubmed/24259408 http://dx.doi.org/10.1093/brain/awt308 |
Ejemplares similares
-
Brain Shuttle Neprilysin reduces central Amyloid-β levels
por: Campos, Christopher R., et al.
Publicado: (2020) -
Engineering Neprilysin Activity and Specificity to Create a Novel Therapeutic for Alzheimer’s Disease
por: Webster, Carl I., et al.
Publicado: (2014) -
Modeling of age-dependent amyloid accumulation and γ-secretase inhibition of soluble and insoluble Aβ in a transgenic mouse model of amyloid deposition
por: Parkinson, Joanna, et al.
Publicado: (2013) -
Development of Immunoassays for the Quantitative Assessment of Amyloid-β in the Presence of Therapeutic Antibody: Application to Pre-Clinical Studies
por: Bogstedt, Anna, et al.
Publicado: (2015) -
The antioxidant xanthorrhizol prevents amyloid-β-induced oxidative modification and inactivation of neprilysin
por: Lim, Chol Seung, et al.
Publicado: (2018)